⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SKYE News
Skye Bioscience, Inc. Common Stock
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
globenewswire.com
SKYE
Skeyeon Secures Key Patent for Very-Low Earth Orbit Satellite Constellations with Onboard Imaging and Direct-to-Ground Data Delivery Enabling Near-Real-Time Earth Observation
businesswire.com
SKYE
Form 8-K
sec.gov
SKYE
Form 8-K
sec.gov
SKYE
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
SKYE
Form 8-K
sec.gov
SKYE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Skye Bioscience, Inc. (SKYE) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
SKYE
Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
SKYE
Bronstein, Gewirtz & Grossman, LLC Encourages Skye Bioscience, Inc. (SKYE) Shareholders to Inquire about Securities Investigation
accessnewswire.com
SKYE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Skye Bioscience, Inc. (SKYE) And Encourages Shareholders to Connect
accessnewswire.com
SKYE